These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27028975)

  • 21. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
    de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
    Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near-infrared light stimuli-responsive synergistic therapy nanoplatforms based on the coordination of tellurium-containing block polymer and cisplatin for cancer treatment.
    Li F; Li T; Cao W; Wang L; Xu H
    Biomaterials; 2017 Jul; 133():208-218. PubMed ID: 28441615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid coordination complex mediates cisplatin entrapment within PEGylated liposome: An implication in colorectal cancer therapy.
    Mirhadi E; Gheybi F; Mahmoudi N; Hemmati M; Soleymanian F; Ghasemi A; Askarizadeh A; Iranshahi M; Jaafari MR; Alavizadeh SH
    Int J Pharm; 2022 Jul; 623():121946. PubMed ID: 35750277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
    Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
    Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
    Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
    Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy.
    Guo S; Wang Y; Miao L; Xu Z; Lin CH; Huang L
    Biomaterials; 2014 Aug; 35(26):7647-53. PubMed ID: 24920436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.
    Ajima K; Murakami T; Mizoguchi Y; Tsuchida K; Ichihashi T; Iijima S; Yudasaka M
    ACS Nano; 2008 Oct; 2(10):2057-64. PubMed ID: 19206452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies.
    Marzban E; Alavizadeh SH; Ghiadi M; Khoshangosht M; Khashayarmanesh Z; Abbasi A; Jaafari MR
    Colloids Surf B Biointerfaces; 2015 Dec; 136():885-91. PubMed ID: 26547316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy.
    Guo S; Wang Y; Miao L; Xu Z; Lin CM; Zhang Y; Huang L
    ACS Nano; 2013 Nov; 7(11):9896-904. PubMed ID: 24083505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and toxicity of cisplatin liposomes modified with polyethylenimine.
    Sun X; Chen J; Gu X; Liang W; Wang J
    Pharmazie; 2014 Apr; 69(4):281-6. PubMed ID: 24791592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary data of the antipancreatic tumor efficacy and toxicity of long-circulating and pH-sensitive liposomes containing cisplatin.
    Carlesso FN; Araújo RS; Fuscaldi LL; Mendes Miranda SE; Rubello D; Teixeira CS; Dos Reis DC; Leite EA; Silveira JN; Fernandes SO; Cassali GD; de Oliveira MC; Colletti PM; de Barros AL; Cardoso VN
    Nucl Med Commun; 2016 Jul; 37(7):727-34. PubMed ID: 27007915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
    Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
    Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
    Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
    Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect.
    Fan X; Zhao X; Qu X; Fang J
    Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison on antitumor activity of cisplatin-loaded liposomes and nanoparticles in vitro].
    Sun XY; Liang WQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 40(4):408-13. PubMed ID: 21845755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.